Crystallographic knowledge bases and their use in rational drug design.

被引:0
|
作者
Bruno, I [1 ]
机构
[1] Cambridge Crystallog Data Ctr, Cambridge CB2 1EZ, England
关键词
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
029-CHED
引用
收藏
页码:U313 / U313
页数:1
相关论文
共 50 条
  • [31] Materials informatics: Knowledge acquisition for materials design.
    Rodgers, JR
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 226 : U302 - U303
  • [32] Evaluation of rational drug use knowledge level in patients with musculoskeletal disorders
    Arikan, Inci
    Ozyigit, Filiz
    [J]. JOURNAL OF BACK AND MUSCULOSKELETAL REHABILITATION, 2019, 32 (01) : 119 - 124
  • [33] Rational drug design
    Reddy, M. Rami
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2007, 13 (34) : 3453 - 3453
  • [34] Rational drug design
    Mandal, Soma
    Moudgil, Mee'nal
    Mandal, Sanat K.
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2009, 625 (1-3) : 90 - 100
  • [35] Rational drug design
    Häyry, P
    [J]. TRANSPLANT IMMUNOLOGY, 2002, 9 (2-4) : 201 - 201
  • [36] ANTIPICORNAVIRUS COMPOUNDS - USE OF RATIONAL DRUG DESIGN AND MOLECULAR MODELING
    DIANA, GD
    NITZ, TJ
    MALLAMO, JP
    TREASURYWALA, A
    [J]. ANTIVIRAL CHEMISTRY & CHEMOTHERAPY, 1993, 4 (01): : 1 - 10
  • [37] Use of drug discovery tools in rational organometallic catalyst design
    Drummond, Michael L.
    Sumpter, Bobby G.
    [J]. INORGANIC CHEMISTRY, 2007, 46 (21) : 8613 - 8624
  • [38] Peptide deformylase: A target for antimicrobial drug design.
    Pei, DH
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 222 : U575 - U575
  • [39] Allostery in the sugar kinase family of enzymes: Attempted rational design.
    Pawlyk, AC
    Pettigrew, DW
    [J]. FASEB JOURNAL, 2000, 14 (08): : A1526 - A1526
  • [40] Ethylene epoxidation on silver: From fundamentals to rational catalyst design.
    Barteau, MA
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 229 : U601 - U601